Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Apr 2, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-03-31$0.57/sh−301$173→ 169,648 total
4 · Nabriva Therapeutics plc · Filed Apr 2, 2020
Ordinary Shares